EUVIMEDEUVIMED entdecken
Crossref

Formulation Development and Evaluation of A Combined Self-Nanoemulsifying Drug Delivery System of Rosuvastatin and Ezetimibe for Enhancing its Dissolution Profile

Saba Nazeer, Hafiz Hanzla Irfan, Shafiullah, Iqra Aslam, Shahzad Tiwana

RADS Journal of Pharmacy and Allied Health Sciences · 06.07.2026 · 4 (1)

DOI: 10.37962/jphs.v4i1.237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RADS Journal of Pharmacy and Allied Health Sciences, online erschienen am 06.07.2026. Verfasst von Saba Nazeer und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Poor water solubility remains a major barrier to the design of many pharmacologically active drugs. Drugs in BCS Class II often have low bioavailability due to their low aqueous solubility, which makes the dissolution process the rate-limiting step.

Objective

To enhance drug release by improving the solubility and membrane permeability of the rosuvastatin-ezetimibe combination. The lipid-based system has been developed as a self-nanoemulsifying drug delivery system (SNEDDS) to co-deliver ezetimibe and rosuvastatin. Methodology: A solubility study of oils, surfactants, and cosurfactants was undertaken using oleic acid, lavender oil, cinnamon oil, isopropyl myristate, Tween 20, Tween 40, Tween 60, Tween 80, Span 20, and propylene glycol. The choice of the oil phase was based on solubility studies, surfactant and cosurfactant screening, and a Smix of Tween 60 and propylene glycol.

Results

ROA-EZT-SNEDDS showed particle size of 161.2 nm, Zeta potential +26.9 mV, polydispersity Index 0.0028. HPLC characterization was used to determine the acceptable drug content, with assay values of 101.92% and 102.64% for rosuvastatin and ezetimibe, respectively. To establish the release profile, dissolution tests were performed based on the USP paddle apparatus (Apparatus II).

Conclusion

Rosuvastatin-Ezetimibe SNEDDS, compared with the traditional Atorvastatin-Ezetimibe, showed better in vitro performance, suggesting a strategy to improve the combination for the control of dyslipidemia.

Zitieren

APA

Nazeer, S., Irfan, H. H., Shafiullah, Aslam, I., & Tiwana, S. (2026). Formulation Development and Evaluation of A Combined Self-Nanoemulsifying Drug Delivery System of Rosuvastatin and Ezetimibe for Enhancing its Dissolution Profile. RADS Journal of Pharmacy and Allied Health Sciences, 4(1). https://doi.org/10.37962/jphs.v4i1.237

Vancouver

Nazeer S, Irfan HH, Shafiullah, Aslam I, Tiwana S. Formulation Development and Evaluation of A Combined Self-Nanoemulsifying Drug Delivery System of Rosuvastatin and Ezetimibe for Enhancing its Dissolution Profile. RADS Journal of Pharmacy and Allied Health Sciences. 2026;4(1). doi:10.37962/jphs.v4i1.237

BibTeX
@article{Nazeer2026,
  author = {Nazeer, Saba and Irfan, Hafiz Hanzla and Shafiullah and Aslam, Iqra and Tiwana, Shahzad},
  title = {Formulation Development and Evaluation of A Combined Self-Nanoemulsifying Drug Delivery System of Rosuvastatin and Ezetimibe for Enhancing its Dissolution Profile},
  journal = {RADS Journal of Pharmacy and Allied Health Sciences},
  year = {2026},
  volume = {4},
  number = {1},
  doi = {10.37962/jphs.v4i1.237}
}
Kostenlos starten →